Urinary Incontinence in Women

Dannecker, Christian; Friese, Klaus; Stief, Christian G.; Bauer, Ricarda

doi:10.3238/arztebl.2010.0420

Cited by 13 publications

(5 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Il comprend le renforcement de la musculature périnéale, la rééduca-tion vésicale et l'amélioration de l'hygiène de vie (arrêt du tabagisme, soulagement de la constipation, diminution de la consommation de café, d'alcool, d'apports liquidiens acides ou basiques deux heures avant le coucher et perte de poids) 60 . Il est recommandé d'augmenter l'intervalle entre les mictions pour supprimer l'urgenturie.…”

Section: Antidépresseursunclassified

“…Il est recommandé d'augmenter l'intervalle entre les mictions pour supprimer l'urgenturie. Les exercices de relâ-chement des muscles du plancher pelvien peuvent entraîner une réduction de l'activité du plancher pelvien et, par voie réflexe, atténuer les symptômes d'urgenturie 60 . Des recherches portent actuellement sur d'autres médi-caments, tels que les agonistes bêta-2 adrénergiques et bêta-3 adrénergiques (mirabegron, isoproténérol) 61 et les antagonistes des neurokinines, des neuropeptides largement impliqués dans le SNC et périphérique.…”

Section: Antidépresseursunclassified

See 1 more Smart Citation

Anticholinergiques et hyperactivité vésicale

Qarro

Asseban²,

Bazine³

et al. 2014

CUAJ

View full text Add to dashboard Cite

Section: Antidépresseursunclassified

Anticholinergiques et hyperactivité vésicale

Qarro

Asseban²,

Bazine³

et al. 2014

CUAJ

View full text Add to dashboard Cite

“…However, none of these drugs are approved for the treatment of SUI and are associated with side effects, that limit the usage 8 . In August 2004, for the first time in Europe, regions of North America, and the Middle East, duloxetine was used to treat women with moderate and severe SUI 9 . Duloxetine is a dual serotonin reuptake inhibitor and norepinephrine (SNRI) 10 .…”

Section: Introductionmentioning

confidence: 99%

“…8 In August 2004, for the first time in Europe, regions of North America, and the Middle East, duloxetine was used to treat women with moderate and severe SUI. 9 Duloxetine is a dual serotonin reuptake inhibitor and norepinephrine (SNRI). 10 It is the first and only drug proposed by ICS to treat SUI and is used as an alternative to surgery in specific cases.…”

mentioning

confidence: 99%

The effect of duloxetine on stress urinary incontinence

Lorzadeh,

Jahanshahi

2024

Health Science Reports

View full text Add to dashboard Cite

Background and AimsThis study aims to evaluate the effect of duloxetine on stress urinary incontinence (SUI) episode frequency (IEF) per week IEF.MethodsIn this clinical trial, 100 women aged 20−80 years with urinary incontinence were assessed based on the standard questionnaire of urinary tract disorders. All the patients received a placebo for 2 weeks. Patients were then randomly divided into two groups of 50 patients each, receiving duloxetine (40 mg twice a day for 12 weeks) and placebo. The two groups were compared in terms of IEF and the mean score of quality of life and side effects.ResultsThe two groups of duloxetine and placebo recipients were matched at the beginning of the study in terms of age, BMI, IEF, parity, and type of delivery. IEF significantly decreased in the duloxetine recipient group compared to the placebo group. The mean score of quality of life in the duloxetine recipient group increased significantly. The rate of study abandonment in the duloxetine recipient group was significantly higher than in the placebo group. Vertigo was the most common complication that caused patients to discontinue the use of the drug.ConclusionDuloxetine is therapeutically effective for SUI in women. Patients should be provided information regarding potential side effects and their management.

show abstract

“…Of the total population 51.75% attended primary and above level of education. The health system in Mekelle is consisting of both public and private that encompass not-for-profit clinics which are run by non-governmental organizations (NGOs) such as MHFC [39] .…”

Section: Study Area and Periodmentioning

confidence: 99%

Predictors of Time to Recovery from a Surgical Repair of Obstetric Fistula at Mekelle Hamlin Fistula Center, Tigray, Ethiopia

Hailu¹

2018

J Preg Child Health

View full text Add to dashboard Cite

Background: Ethiopia is one of the high fistula burdened countries in the world with an annual occurrence of 3,500 new and existence of 37,500 untreated obstetric fistula cases. Studies conducted in this area focus on determinants of obstetric fistula before surgical repair and researches addressing the associated factors are limited.Objective: To estimate time to recovery from a surgical repair of obstetric fistula and its associated factors among patients treated at Mekelle Hamlin Fistula Center. Results: The patients were followed for 6657 person days at risk, the median recovery time was 20 days. The overall recovery rate was 2.5 cases per 100 person days. Multivariable Cox proportional hazard model result showed labor duration of two or more days (AHR=0.73, 95% CI=0.53, 0.99) and post-operative bladder catheterization longer than 14 or more days (AHR=0.45, 95% CI=0.32, 0.62) were factors negatively associated with recovery time from obstetric fistula surgery. Methods Conclusion and recommendations:women who experienced labor of two or more days and post-operative bladder drainage for more than two or more weeks took longer time to recover after the repair. Therefore, Decision makers, Health care professionals, Stakeholders and Researchers should give emphasis on activities that reduce delays' in decision making, delays' in giving urgent intervention and delays' in reaching health institutions that contributes in reducing complications of prolonged labor ultimately obstetric fistula.Harmful traditional practices such as early marriage and home delivery are other potential factors for the development of obstetric fistula [8][9][10]. Globally, nine to 84% of obstetric fistula patients gave birth at home and more than 2 million women are currently living with this problem. Additional 50,000 to 100,000 new cases are estimated to occur each year and majority of which are from Africa and Asia [9][10][11][12][13].Incidence rates of obstetric fistula in countries with high maternal mortality is as high as two to three cases per 1000 women [14]. Estimated incidence and prevalence of untreated obstetric fistula in Ethiopia during the year 2010 was 3,500 and 37,500, respectively [9,15]. Introduction BackgroundObstetric fistula is an injury that occurs during prolonged or obstructed labor causing tissue damage to organs inside the pelvis and resulting in incontinence of urine, feces or both. The dead tissues due to prolonged pressure fall away and a hole will be formed between the vagina and bladder called Vesico-vaginal Fistula (VVF) or between the vagina and rectum called Recto Vaginal Fistula (RVF) [1][2][3].Obstetric fistula is the worst child birth related complication that contributes for 2.5% of the Global daily death of mothers associated with child birth related complications [4].The main causes of obstetric fistula in the developed world are radiation therapy and surgery whereas in developing countries, "the three delays" are responsible, the delay in seeking skilled emergency obstetric care, the del...

show abstract

Urinary Incontinence in Women

Abstract: All women with urinary incontinence should undergo appropriate, specialized diagnostic evaluation and well-founded counseling in order to benefit from individualized treatment.

Cited by 13 publications

References 27 publications

Anticholinergiques et hyperactivité vésicale

Anticholinergiques et hyperactivité vésicale

The effect of duloxetine on stress urinary incontinence

Predictors of Time to Recovery from a Surgical Repair of Obstetric Fistula at Mekelle Hamlin Fistula Center, Tigray, Ethiopia

Contact Info

Product

Resources

About